BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hermans MM, Vermeer C, Kooman JP, Brandenburg V, Ketteler M, Gladziwa U, Rensma PL, Leunissen KM, Schurgers LJ. Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index. Blood Purif. 2007;25:395-401. [PMID: 17890861 DOI: 10.1159/000108629] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Danziger J. Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin J Am Soc Nephrol 2008;3:1504-10. [PMID: 18495950 DOI: 10.2215/CJN.00770208] [Cited by in Crossref: 168] [Cited by in F6Publishing: 54] [Article Influence: 12.0] [Reference Citation Analysis]
2 Kanbay M, Afsar B, Gusbeth-tatomir P, Covic A. Arterial stiffness in dialysis patients: where are we now? Int Urol Nephrol 2010;42:741-52. [DOI: 10.1007/s11255-009-9675-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
3 Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M, Shlipak MG, Whooley MA, Ix JH. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med 2010;152:640-8. [PMID: 20479029 DOI: 10.7326/0003-4819-152-10-201005180-00004] [Cited by in Crossref: 324] [Cited by in F6Publishing: 289] [Article Influence: 27.0] [Reference Citation Analysis]
4 Noordzij M, Cranenburg EM, Engelsman LF, Hermans MM, Boeschoten EW, Brandenburg VM, Bos WJ, Kooman JP, Dekker FW, Ketteler M. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant. 2011;26:1662-1669. [PMID: 20880929 DOI: 10.1093/ndt/gfq582] [Cited by in Crossref: 89] [Cited by in F6Publishing: 79] [Article Influence: 7.4] [Reference Citation Analysis]
5 Delanaye P, Krzesinski JM, Warling X, Moonen M, Smelten N, Médart L, Pottel H, Cavalier E. Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol. 2014;15:145. [PMID: 25190488 DOI: 10.1186/1471-2369-15-145] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
6 New N, Mohandas J, John GT, Ratanjee S, Healy H, Francis L, Ranganathan D. Calcific uremic arteriolopathy in peritoneal dialysis populations. Int J Nephrol 2011;2011:982854. [PMID: 21748002 DOI: 10.4061/2011/982854] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
7 Antonopoulos S, Mylonopoulou M, Angelidi AM, Kousoulis AA, Tentolouris N. Association of matrix γ-carboxyglutamic acid protein levels with insulin resistance and Lp(a) in diabetes: A cross-sectional study. Diabetes Res Clin Pract 2017;130:252-7. [PMID: 28654853 DOI: 10.1016/j.diabres.2017.06.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
8 Gungor O, Kocyigit I, Yilmaz MI, Sezer S. Role of vascular calcification inhibitors in preventing vascular dysfunction and mortality in hemodialysis patients. Semin Dial 2018;31:72-81. [DOI: 10.1111/sdi.12616] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
9 Pivin E, Ponte B, Pruijm M, Ackermann D, Guessous I, Ehret G, Liu YP, Drummen NE, Knapen MH, Pechere-Bertschi A, Paccaud F, Mohaupt M, Vermeer C, Staessen JA, Vogt B, Martin PY, Burnier M, Bochud M. Inactive Matrix Gla-Protein Is Associated With Arterial Stiffness in an Adult Population-Based Study. Hypertension 2015;66:85-92. [PMID: 25987667 DOI: 10.1161/HYPERTENSIONAHA.115.05177] [Cited by in Crossref: 58] [Cited by in F6Publishing: 38] [Article Influence: 8.3] [Reference Citation Analysis]
10 Delanaye P, Liabeuf S, Bouquegneau A, Cavalier É, Massy ZA. L’éveil de la matrix-gla-protéine sonnera le glas des calcifications vasculaires. Néphrologie & Thérapeutique 2015;11:191-200. [DOI: 10.1016/j.nephro.2014.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
11 Wyskida K, Żak-Gołąb A, Wajda J, Klein D, Witkowicz J, Ficek R, Rotkegel S, Spiechowicz U, Kocemba Dyczek J, Ciepał J, Olszanecka-Glinianowicz M, Więcek A, Chudek J. Functional deficiency of vitamin K in hemodialysis patients in Upper Silesia in Poland. Int Urol Nephrol 2016;48:765-71. [PMID: 27000106 DOI: 10.1007/s11255-016-1255-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
12 Kaesler N, Schurgers LJ, Floege J. Vitamin K and cardiovascular complications in CKD patients. Kidney Int 2021:S0085-2538(21)00687-6. [PMID: 34310988 DOI: 10.1016/j.kint.2021.06.037] [Reference Citation Analysis]
13 Wang AY. Vascular and Other Tissue Calcification in Peritoneal Dialysis Patients. Perit Dial Int 2009;29:9-14. [DOI: 10.1177/089686080902902s01] [Cited by in Crossref: 21] [Article Influence: 1.6] [Reference Citation Analysis]
14 Roumeliotis S, Dounousi E, Eleftheriadis T, Liakopoulos V. Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review. Int J Mol Sci 2019;20:E628. [PMID: 30717170 DOI: 10.3390/ijms20030628] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
15 Ueland T, Gullestad L, Dahl CP, Aukrust P, Aakhus S, Solberg OG, Vermeer C, Schurgers LJ. Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis. J Intern Med 2010;268:483-92. [PMID: 20804515 DOI: 10.1111/j.1365-2796.2010.02264.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 6.1] [Reference Citation Analysis]
16 Gluba-Brzózka A, Michalska-Kasiczak M, Franczyk B, Nocuń M, Toth P, Banach M, Rysz J. Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. Lipids Health Dis 2016;15:22. [PMID: 26843213 DOI: 10.1186/s12944-016-0191-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
17 Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, Vermeer C, Choukroun G, Massy ZA. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol. 2010;5:568-575. [PMID: 20133489 DOI: 10.2215/cjn.07081009] [Cited by in Crossref: 180] [Cited by in F6Publishing: 83] [Article Influence: 15.0] [Reference Citation Analysis]
18 Nazifova-Tasinova NF, Atanasov AA, Pasheva MG, Yotov YT, Gerova DI, Vankova DG, Todorova MN, Ivanova DG, Kiselova-Kaneva YD, Galunska BT. Circulating uncarboxylated matrix Gla protein in patients with atrial fibrillation or heart failure with preserved ejection fraction. Arch Physiol Biochem 2020;:1-11. [PMID: 32620059 DOI: 10.1080/13813455.2020.1786130] [Reference Citation Analysis]
19 Schlieper G, Westenfeld R, Krüger T, Cranenburg EC, Magdeleyns EJ, Brandenburg VM, Djuric Z, Damjanovic T, Ketteler M, Vermeer C, Dimkovic N, Floege J, Schurgers LJ. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol 2011;22:387-95. [PMID: 21289218 DOI: 10.1681/ASN.2010040339] [Cited by in Crossref: 159] [Cited by in F6Publishing: 69] [Article Influence: 14.5] [Reference Citation Analysis]
20 Hariri E, Kassis N, Iskandar JP, Schurgers LJ, Saad A, Abdelfattah O, Bansal A, Isogai T, Harb SC, Kapadia S. Vitamin K2-a neglected player in cardiovascular health: a narrative review. Open Heart 2021;8:e001715. [PMID: 34785587 DOI: 10.1136/openhrt-2021-001715] [Reference Citation Analysis]
21 Krueger T, Westenfeld R, Schurgers L, Brandenburg V. Coagulation meets calcification: the vitamin K system. Int J Artif Organs 2009;32:67-74. [PMID: 19363777 DOI: 10.1177/039139880903200202] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
22 Roumeliotis S, Roumeliotis A, Dounousi E, Eleftheriadis T, Liakopoulos V. Biomarkers of vascular calcification in serum. Adv Clin Chem 2020;98:91-147. [PMID: 32564789 DOI: 10.1016/bs.acc.2020.02.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
23 Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M, Shlipak MG, Whooley MA, Ix JH. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med 2010;152:640-8. [PMID: 20479029 DOI: 10.7326/0003-4819-152-10-201005180-00004] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Cai Y, Xu M, Teng X, Zhou YB, Chen L, Zhu Y, Wang X, Tang CS, Qi YF. Intermedin inhibits vascular calcification by increasing the level of matrix γ-carboxyglutamic acid protein. Cardiovascular Research 2010;85:864-73. [DOI: 10.1093/cvr/cvp366] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
25 Nemcsik J, Kiss I, Tislér A. Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease. World J Nephrol 2012; 1(1): 25-34 [PMID: 24175239 DOI: 10.5527/wjn.v1.i1.25] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
26 McCann JC, Ames BN. Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? Am J Clin Nutr 2009;90:889-907. [PMID: 19692494 DOI: 10.3945/ajcn.2009.27930] [Cited by in Crossref: 128] [Cited by in F6Publishing: 105] [Article Influence: 9.8] [Reference Citation Analysis]
27 Krueger T, Westenfeld R, Ketteler M, Schurgers LJ, Floege J. Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification? Kidney International 2009;76:18-22. [DOI: 10.1038/ki.2009.126] [Cited by in Crossref: 70] [Cited by in F6Publishing: 58] [Article Influence: 5.4] [Reference Citation Analysis]
28 Ponziani FR, Pompili M, Di Stasio E, Zocco MA, Gasbarrini A, Flore R. Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms. World J Gastroenterol 2017; 23(7): 1241-1249 [PMID: 28275304 DOI: 10.3748/wjg.v23.i7.1241] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
29 Wang AY. Vascular and valvular calcification in chronic peritoneal dialysis patients. Int J Nephrol 2011;2011:198045. [PMID: 21826268 DOI: 10.4061/2011/198045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
30 Parker BD, Schurgers LJ, Vermeer C, Schiller NB, Whooley MA, Ix JH. The association of uncarboxylated matrix Gla protein with mitral annular calcification differs by diabetes status: The Heart and Soul study. Atherosclerosis. 2010;210:320-325. [PMID: 20015492 DOI: 10.1016/j.atherosclerosis.2009.11.023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
31 Kim J, Lee W, Kim J. Therapeutic strategy for atherosclerosis based on bone-vascular axis hypothesis. Pharmacology & Therapeutics 2020;206:107436. [DOI: 10.1016/j.pharmthera.2019.107436] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
32 Parker BD, Ix JH, Cranenburg EC, Vermeer C, Whooley MA, Schurgers LJ. Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study. Nephrol Dial Transplant. 2009;24:2095-2101. [PMID: 19204017 DOI: 10.1093/ndt/gfp024] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
33 Toussaint ND. Extracellular matrix calcification in chronic kidney disease: . Current Opinion in Nephrology and Hypertension 2011;20:360-8. [DOI: 10.1097/mnh.0b013e3283479330] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
34 Manghat P, Souleimanova I, Cheung J, Wierzbicki AS, Harrington DJ, Shearer MJ, Chowienczyk P, Fogelman I, Goldsmith D, Hampson G. Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD). Bone. 2011;48:1127-1132. [PMID: 21281749 DOI: 10.1016/j.bone.2011.01.016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
35 Fain ME, Kapuku GK, Paulson WD, Williams CF, Raed A, Dong Y, Knapen MHJ, Vermeer C, Pollock NK. Inactive Matrix Gla Protein, Arterial Stiffness, and Endothelial Function in African American Hemodialysis Patients. Am J Hypertens. 2018;31:735-741. [PMID: 29635270 DOI: 10.1093/ajh/hpy049] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
36 Cozzolino M, Cianciolo G, Podestà MA, Ciceri P, Galassi A, Gasperoni L, Manna G. Current Therapy in CKD Patients Can Affect Vitamin K Status. Nutrients 2020;12:E1609. [PMID: 32486167 DOI: 10.3390/nu12061609] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Albu A, Fodor D, Bondor C, Crăciun A. Bone metabolism regulators and arterial stiffness in postmenopausal women. Maturitas 2013;76:146-50. [DOI: 10.1016/j.maturitas.2013.07.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
38 Puzantian H, Akers SR, Oldland G, Javaid K, Miller R, Ge Y, Ansari B, Lee J, Suri A, Hasmath Z, Townsend R, Chirinos JA. Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness. Am J Hypertens 2018;31:988-94. [PMID: 29788226 DOI: 10.1093/ajh/hpy079] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
39 Liabeuf S, Okazaki H, Desjardins L, Fliser D, Goldsmith D, Covic A, Wiecek A, Ortiz A, Martinez-castelao A, Lindholm B, Suleymanlar G, Mallamaci F, Zoccali C, London G, Massy ZA. Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario? Nephrology Dialysis Transplantation 2014;29:1275-84. [DOI: 10.1093/ndt/gft368] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 4.2] [Reference Citation Analysis]